Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Methylergometrine (0.125mg)
Dosage Form : Tablet
Packaging Type : Blister
Packaging : 10*10
Price : ₹1/-
Methezen 0.125 Tablet contains Methylergometrine 0.125mg, a medication primarily used in obstetrics and gynecology. Methylergometrine is a derivative of ergot alkaloid and works by stimulating smooth muscle contraction in the uterus. This makes it an essential drug for controlling postpartum hemorrhage (excessive bleeding following childbirth). It is also effective in promoting the contraction of the uterus after delivery to help expel the placenta and reduce bleeding.
In addition to its role in postpartum care, Methylergometrine is also used to treat certain conditions related to uterine atony (a lack of muscle tone in the uterus), which can result in excessive bleeding. By increasing the strength and frequency of uterine contractions, it helps to minimize bleeding and ensures the safe recovery of the patient.
Common side effects include nausea, vomiting, headache, dizziness, and high blood pressure. Prolonged use may cause uterine hypertonia.
Used for controlling postpartum hemorrhage and treating uterine atony.
Use only under medical supervision, especially in patients with hypertension or cardiovascular conditions. Not recommended during pregnancy unless prescribed by a doctor.
Store at room temperature in a cool, dry place, away from moisture and sunlight. Keep out of reach of children.
Composition : Bromfenac (0.09% w/v) + Moxifloxacin (0.5% w/v)
Composition : Bromfenac (0.9mg) Eye Drops
Composition : Carboxymethylcellulose (3mg/ml) + Glycerin (10mg/ml) + n-acetylcarnosine (10mg/ml)
Composition : Dexamethasone (0.1% w/v) + Tobramycin (0.3% w/v)
Composition : Fluconazole (0.3% w/v)
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)
Composition : Ketorolac (0.5% w/v)
Composition : Ketorolac (5% w/v) + Moxifloxacin (0.5% w/v)
Composition : Loteprednol etabonate (0.5% w/v)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation